Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-072916
Filing Date
2012-02-22
Accepted
2012-02-22 16:53:02
Documents
8
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d275255d10k.htm 10-K 1210216
2 CONSENT OF OUM & CO. LLP d275255dex231.htm EX-23.1 2070
3 CONSENT OF BDO USA, LLC d275255dex232.htm EX-23.2 2078
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)/15D-14(A) d275255dex311.htm EX-31.1 6000
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)/15D-14(A) d275255dex312.htm EX-31.2 6056
6 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(B)/15D-14(B) d275255dex321.htm EX-32.1 2462
7 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(B)/15D-14(B) d275255dex322.htm EX-32.2 2608
8 GRAPHIC g275255g50z21.jpg GRAPHIC 63718
  Complete submission text file 0001193125-12-072916.txt   1320559
Mailing Address 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807
Business Address 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807 714-786-4200
QUESTCOR PHARMACEUTICALS INC (Filer) CIK: 0000891288 (see all company filings)

EIN.: 330476164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14758 | Film No.: 12630990
SIC: 2834 Pharmaceutical Preparations